Concepedia

Michael Grundman

MG

85

Publications

21K

Citations

52

H-Index

1982

Active since

Affiliations

University of California San Diego(Current)

University College London

Pfizer (United States)

Janssen (United States)

Harvard University

Michael Grundman is an author at University of California San Diego specializing in medicine, neurology, and alzheimer's disease.

Top concepts

Publications per year

1982–2024

85

Publications

85

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

Mary Sano, Christopher Ernesto, Ronald G. Thomas et al. · New England Journal of Medicine · 1997 · 2.4K citations · Full text

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Stephen Salloway, Reisa A. Sperling, Nick C. Fox et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

Ronald Petersen, Ronald G. Thomas, Michael Grundman et al. · New England Journal of Medicine · 2005 · 1.8K citations · Full text

An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimerʼs Disease

Douglas Galasko, David A. Bennett, Mary Sano et al. · Alzheimer Disease & Associated Disorders · 1997 · 1.2K citations

, , +17

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.

Ruth A. Mulnard, Carl W. Cotman, Claudia H. Kawas et al. · PubMed · 2000 · 985 citations · Full text

Rows per page

1–5 of 85